retatrutide parkinson clinical trial Diabetes Dialogue: Reduces Body Weight 28.7% in Phase 3 retatrutide clinical trial parkinson retatrutide
Description
The compliance monitoring gap is under scrutiny
Are the benefits real
Food & Drug Administration (2021) FDA approves first generic of once-daily GLP-1 injection to lower blood sugar in patients with type 2 diabetes, U.S
Previously, there had only been one oral drug for this indication: metformin, which was approved in 2000
